Last reviewed · How we verify

NCT05426538: CROCUS

Craving to Biologics Used in Severe Asthma

Completed Last updated 24 August 2022
What this trial tests

trial in Asthma in 150 participants. Completed in 1 August 2022.

Timeline
10 December 2021
Primary endpoint
1 July 2022
1 August 2022

Quick facts

Lead sponsorFrisius Medisch Centrum
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date10 December 2021
Primary completion1 July 2022
Estimated completion1 August 2022
Sites1 location across Netherlands

Conditions studied

Sponsor

Frisius Medisch Centrum — full company profile →

Who can join

18 and older, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Some patients treated with biologics for severe asthma experience a craving to the next biological administration. This phenomenon has never been described before. In this study, the researchers aim to further elucidate the feeling of needing the next administration of a biologic for severe asthma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Frisius Medisch Centrum trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing